about
Prognostic values of EORTC QLQ-C30 and QLQ-HCC18 index-scores in patients with hepatocellular carcinoma - clinical application of health-related quality-of-life data.Adjuvant S-1 chemotherapy after curative resection of gastric cancer in Chinese patients: assessment of treatment tolerability and associated risk factors.Phase I/II study of temsirolimus for patients with unresectable Hepatocellular Carcinoma (HCC)- a correlative study to explore potential biomarkers for responseColorectal cancer in Chinese patients: current and emerging treatment options.Phase I, multicenter, open-label, dose-escalation study of sonidegib in Asian patients with advanced solid tumorsA phase 2 study of the efficacy and biomarker on the combination of transarterial chemoembolization and axitinib in the treatment of inoperable hepatocellular carcinoma.Multicenter phase II study of the AKT inhibitor MK-2206 in recurrent or metastatic nasopharyngeal carcinoma from patients in the mayo phase II consortium and the cancer therapeutics research group (MC1079).Applicability of BALAD score in prognostication of hepatitis B-related hepatocellular carcinoma.Ablative Chemoembolization for Hepatocellular Carcinoma: A Prospective Phase I Case-Control Comparison with Conventional Chemoembolization.Efficacy, Safety, and Pharmacokinetics of Axitinib in Nasopharyngeal Carcinoma: A Preclinical and Phase II Correlative Study.Prospective evaluation of plasma Epstein-Barr virus DNA clearance and fluorodeoxyglucose positron emission scan in assessing early response to chemotherapy in patients with advanced or recurrent nasopharyngeal carcinoma.Quality of life of young Chinese breast cancer patients after adjuvant chemotherapy.Status of inflammation in relation to health related quality of life in hepatocellular carcinoma patients
P50
Q31152723-D346D660-A6B0-40FA-88B1-0C0A4D0DC30CQ33168017-05B56D98-CE24-4D70-BE53-773D0EB77D91Q33422744-6888F85A-F5B0-457C-B673-9E6137706EE3Q34352595-074E9BEB-D548-4A4F-8D76-FF16587442CBQ37375259-AA7EFFA3-33D7-4F49-93F3-421920D9BE04Q38375159-80300556-27B3-47BD-A9CD-799577DDDEE6Q38385856-445E8A7D-A96F-40A4-AC1D-CDF6890E2998Q38386410-B4C63E77-03F5-4D92-A7F6-662658D19346Q49618717-61590D30-18BD-4D0C-AB40-933F25F06B4EQ50187428-284A5CA5-6D3F-48D2-9CA2-8F5CC05B4BD8Q52647899-9A97368F-6169-4ED0-B4E8-ED00B1491F02Q54942232-99C287E0-B051-4F86-B75A-E033C4B656FBQ91628777-363234D2-AFFD-4A18-BE34-980B98FF5EBA
P50
description
researcher (ORCID 0000-0002-0251-0253)
@en
name
L Li
@en
type
label
L Li
@en
prefLabel
L Li
@en
P31
P496
0000-0002-0251-0253